Russell Investments Group, Ltd.
Position in SGMOQ — Sangamo Therapeutics, Inc
CIK 1692234
Seattle, WA
Position in SGMOQ
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$17,194
-$3,955 QoQ
Shares Held
68,778
+36.6% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SGMOQ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
336,990 | $167,393,033 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
230,151 | $143,508,345 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,694,250 | $94,996,587 | |
| 4 | INCY |
Incyte Corp
|
425,616 | $48,247,822 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
158,228 | $47,631,369 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
783,148 | $44,811,725 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
120,304 | $38,026,888 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
418,025 | $34,098,295 |
All Filings in SGMOQ
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,194 | 68,778 | Shares | Other | 2026-05-08 | |
| 2025-12-31 | $21,149 | 50,357 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $33,936 | 50,653 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $17,899 | 33,148 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $21,946 | 33,253 | Shares | Other | 2025-05-13 | |
| 2024-12-31 | $26,839 | 26,314 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $35,501 | 40,806 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $8,126 | 22,577 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $4,205 | 6,278 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $54,550 | 101,022 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $61,379 | 102,301 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $136,092 | 104,688 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $344,792 | 195,906 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $318,273 | 101,361 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $496,668 | 101,361 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $138,276 | 33,400 | Shares | Defined | 2022-07-29 | |
| 2021-03-31 | $973,756 | 77,714 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $1,718,395 | 110,083 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $1,104,430 | 116,871 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $971,004 | 108,371 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $364,873 | 57,280 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||